Atlas Trials

Study Evaluating Etanercept in Moderate to Severe Asthma

Clinical trial NCT00141791 · COMPLETED

Trial details

NCT number
NCT00141791
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2005-05-01
Primary completion
2006-07-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.